Purple Biotech Ltd.
PPBT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $12,127 | $18,969 | $25,504 | $69,242 |
| - Cash | $7,401 | $14,489 | $15,030 | $10,890 |
| + Debt | $183 | $351 | $515 | $749 |
| Enterprise Value | $4,909 | $4,831 | $10,989 | $59,101 |
| Revenue | $0 | $196 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Gross Profit | -$186 | -$0 | -$0 | -$0 |
| % Margin | – | -0.1% | – | – |
| EBITDA | -$7,052 | -$19,875 | -$21,492 | -$17,516 |
| % Margin | – | -10,150.5% | – | – |
| Net Income | -$7,240 | -$20 | -$21,668 | -$18,384 |
| % Margin | – | -10.2% | – | – |
| EPS Diluted | -4.42 | -0.16 | -0.23 | -0.21 |
| % Growth | -2,662.5% | 30.4% | -9.5% | – |
| Operating Cash Flow | -$14,367 | -$19,925 | -$16,735 | -$15,071 |
| Capital Expenditures | $0 | -$3 | -$228 | -$115 |
| Free Cash Flow | -$14,367 | -$19,928 | -$16,963 | -$15,186 |